The Dubai Market
Dubai is the Gulf's primary market for Pharmaceuticals & Life Sciences technology — and the regulatory environment is more sophisticated than Western firms typically assume. The UAE PDPL, DIFC Data Protection Law (for DIFC entities), DHA/MOHAP sector-specific requirements, and the NESA cybersecurity framework create overlapping compliance obligations that require current, Dubai-specific regulatory knowledge.
Pharmaceuticals & Life Sciences organizations in Dubai operate across a regulatory mosaic that includes Emirate-level, federal UAE, and free zone frameworks — each with distinct requirements. Engineering teams that apply a generic 'Middle East compliance' approach discover the gaps during TDRA or sector regulator review. We deploy with the Dubai regulatory landscape mapped at the system architecture level.
Compliance Coverage
Every system we deploy for Pharmaceuticals & Life Sciences in Dubai is FDA 21 CFR Part 11-compliant from architecture through deployment. FDA 21 CFR Part 11 and HIPAA compliance is enforced automatically at every commit — not assessed after the fact.
Engagement Scope
Duration: 8–16 weeks
A focused team deployed against a single Pharmaceuticals & Life Sciences platform in Dubai. FDA 21 CFR Part 11 and HIPAA-compliant architecture from day one. Fixed price, fixed output, no discovery phase.
Duration: 3–9 months
40–100 engineers running parallel workstreams across a Pharmaceuticals & Life Sciences transformation in Dubai. Multi-system compliance governance and FDA 21 CFR Part 11 and HIPAA certification maintained across the full program.
Duration: 6–18 months
100–250+ engineers owning the complete technology infrastructure for a Pharmaceuticals & Life Sciences organization in Dubai. Full FDA 21 CFR Part 11 and HIPAA compliance across every system, every integration, every deployment.